Differential modulation of neurons in the rostral ventromedial medulla by neurokin-1 receptors
Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis 55455, USA. Journal of Neurophysiology
(Impact Factor: 2.89).
02/2012; 107(4):1210-21. DOI: 10.1152/jn.00678.2011
The rostral ventromedial medulla (RVM) is part of descending circuitry that modulates nociceptive processing at the level of the spinal cord. RVM output can facilitate pain transmission under certain conditions such as inflammation, and thereby contribute to hyperalgesia. Evidence suggests that substance P and activation of neurokinin-1 (NK-1) receptors in the RVM are involved in descending facilitation of nociception. We showed previously that injection of NK-1 receptor antagonists into the RVM attenuated mechanical and heat hyperalgesia produced by intraplantar injection of capsaicin. Furthermore, intraplantar injection of capsaicin excited ON cells in the RVM and inhibited ongoing activity of OFF cells. In the present studies, we therefore examined changes in responses of RVM neurons to mechanical and heat stimuli after intraplantar injection of capsaicin and determined the role of NK-1 receptors by injecting a NK-1 receptor antagonist into the RVM prior to capsaicin. After capsaicin injection, excitatory responses of ON cells and inhibitory responses of OFF cells evoked by mechanical and heat stimuli applied to the injected, but not contralateral, paw were increased. Injection of the NK-1 antagonist L-733,060 did not alter evoked responses of ON or OFF cells but attenuated the capsaicin-evoked enhanced responses of ON cells to mechanical and heat stimuli with less of an effect on the enhanced inhibitory responses of OFF cells. These data support the notion that descending facilitation from RVM contributes to hyperalgesia and that NK-1 receptors, presumably located on ON cells, play an important role in initiating descending facilitation of nociceptive transmission.
Available from: Marta Hamity
- "Iontophoretic application of Sub P excites ON cells, a population of putative pain facilitatory neurons in the RVM (Budai et al., 2007). Moreover, the enhanced ON cell activity observed in rats that received ipl injection of capsaicin can be blocked by iontophoresis of a NK1R antagonist in the RVM (Budai et al., 2007; Brink et al., 2012). However, several other mechanisms may contribute to the pronociceptive role of Sub P. One possibility is an upregulation in the number or affinity of NK1R in the RVM. "
[Show abstract] [Hide abstract]
ABSTRACT: This study examined possible mechanisms by which Substance P (Sub P) assumes a pronociceptive role in the rostral ventromedial medulla (RVM) under conditions of peripheral inflammatory injury, in this case produced by intraplantar (ipl) injection of complete Freund's adjuvant (CFA). In saline and CFA-treated rats, neurokinin-1 receptor (NK1R) immunoreactivity was localized to neurons in the RVM. Four days after ipl injection of CFA, the number of NK1R immunoreactive neurons in the RVM was increased by 30%, and there was a concomitant increase in NK1R immunoreactive processes in CFA-treated rats. Although NK1R immunoreactivity was increased, tachykinin-1 receptor (Tacr1) mRNA was not increased in the RVM of CFA-treated rats. To assess changes in Sub P release, the number of RVM neurons that exhibited NK1R internalization was examined in saline- and CFA-treated rats following noxious heat stimulation of the hind paws. Only CFA-treated rats that experienced noxious heat stimulation exhibited a significant increase in the number of neurons showing NK1R internalization. These data suggest that tonic Sub P release is not increased as a simple consequence of peripheral inflammation, but that phasic or evoked release of Sub P in the RVM is increased in response to noxious peripheral stimulation in a persistent inflammatory state. These data support the proposal that an upregulation of the NK1R in the RVM, as well as enhanced release of Sub P following noxious stimulation underlie the pronociceptive role of Sub P under conditions of persistent inflammatory injury. J. Comp. Neurol., 2014. © 2014 Wiley Periodicals, Inc.
The Journal of Comparative Neurology 09/2014; 522(13). DOI:10.1002/cne.23564 · 3.23 Impact Factor
Available from: Yoshihiro Nakata
- "Lesioning of the RVM or injection of local anesthetic into the RVM blocks the development of injury-induced cutaneous hypersensitivity. Moreover, disabling the RVM 'facilitatory pathway,' after microinjection with either short hairpin RNA (shRNA) to block expression of tryptophan hydroxylase-2, the rate-limiting enzyme in the synthesis of neuronal serotonin, or lidocaine, attenuate the tonic, but not the early or phasic, phase of formalin-induced nociception, and capsaicin-evoked mechanical hypersensitivity (Pacharinsak et al. 2008; Wei et al. 2010; Brink et al. 2012). The RVM contains physiologically defined neurons which both inhibit and facilitate nociceptive processing at the level of the spinal dorsal horn (Urban and Gebhart 1999). "
[Show abstract] [Hide abstract]
ABSTRACT: Intraplantar injection of 0.4% formalin into the rat hind paw leads to a biphasic nociceptive response; an "acute" phase (0-15 min) and "tonic" phase (16-120 min), which is accompanied by significant phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 in the contralateral striatum at 120 min post-formalin injection. To uncover a possible relationship between the slow-onset substance P (SP) release and increased ERK1/2 phosphorylation in the striatum, continuous infusion of SP into the striatum by reverse microdialysis (0.4 μg/mL in microdialysis fiber, 1 μL/min) was performed to mimic volume neurotransmission of SP. Continuous infusion for 3 hr of SP reduced the duration of "tonic" phase nociception, and this SP effect was mediated by NK1 receptors since pretreatment with the NK1R antagonist CP96345 (10 μM) blocked the effect of SP infusion. However, formalin induced "tonic" phase nociception was significantly prolonged following acute injection of the MEK1/2 inhibitor PD0325901 (100 pmol) by microinjection. The co-infusion of SP and PD0325901 significantly increased the "tonic" phase of nociception. These data demonstrate that volume transmission of striatal SP triggered by peripheral nociceptive stimulation does not lead to pain facilitation but a significant decrease of tonic nociception by the activation of the SP-NK1R-ERK1/2 system. This article is protected by copyright. All rights reserved.
Journal of Neurochemistry 08/2014; 131(6). DOI:10.1111/jnc.12938 · 4.28 Impact Factor
Available from: Wei Guo
- "Immunohistochemical localization shows moderate amounts of the substance P receptor, neurokinin-1 receptor (NK1-R), in the RVM
[15-17]. Research has shown that Substance P activation of NK1-R in the RVM is involved in descending facilitation of pain
[18-25]. We have also shown that the serotonin system is involved in descending facilitation in the spinal cord after tissue and nerve injury
[Show abstract] [Hide abstract]
Our previous studies have shown that complete Freund’s adjuvant (CFA)-induced masseter inflammation and microinjection of the pro-inflammatory cytokine interleukin-1β (IL-1β) into the subnucleus interpolaris/subnucleus caudalis transition zone of the spinal trigeminal nucleus (Vi/Vc) can induce contralateral orofacial hyperalgesia in rat models. We have also shown that contralateral hyperalgesia is attenuated with a lesion of the rostral ventromedial medulla (RVM), a critical site of descending pain modulation. Here we investigated the involvement of the RVM-Vi/Vc circuitry in mediating contralateral orofacial hyperalgesia after an injection of CFA into the masseter muscle.
Microinjection of the IL-1 receptor antagonist (5 nmol, n=6) into the ipsilateral Vi/Vc attenuated the CFA-induced contralateral hyperalgesia but not the ipsilateral hyperalgesia. Intra-RVM post-treatment injection of the NK1 receptor antagonists, RP67580 (0.5-11.4 nmol) and L-733,060 (0.5-11.4 nmol), attenuated CFA-induced bilateral hyperalgesia and IL-1β induced bilateral hyperalgesia. Serotonin depletion in RVM neurons prior to intra-masseter CFA injection prevented the development of contralateral hyperalgesia 1–3 days after CFA injection. Inhibition of 5-HT3 receptors in the contralateral Vi/Vc with direct microinjection of the select 5-HT3 receptor antagonist, Y-25130 (2.6-12.9 nmol), attenuated CFA-induced contralateral hyperalgesia. Lesions to the ipsilateral Vc prevented the development of ipsilateral hyperalgesia but did not prevent the development of contralateral hyperalgesia.
These results suggest that the development of CFA-induced contralateral orofacial hyperalgesia is mediated through descending facilitatory mechanisms of the RVM-Vi/Vc circuitry.
Molecular Pain 10/2012; 8(1):78. DOI:10.1186/1744-8069-8-78 · 3.65 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.